ライフサイエンスコーパス: implant

1 odontal disease (e.g., crown lengthening and implants).

2 ture search involved the use of this type of implant.

3 ty events were assessed out to 6 months post-implant.

4 ercept, triamcinolone, and the dexamethasone implant.

5 not recover after intravitreal dexamethasone implant.

6 al mastectomy, nodal surgery, tissue, and/or implant.

7 ve environment at the site of a subcutaneous implant.

8 nth, 3 months, 1 year, and 2 years after ICL implant.

9 hat did evaluate this metric involved porous implants.

10 They also cause biocorrosion of medical implants.

11 the limitations of morphological imaging in implants.

12 xytol enhancement than did matched stem cell implants.

13 tter visual outcome after treatment with DEX implants.

14 1, 2, and 4 months after treatment with DEX implants.

15 led to significant clinical improvements at implants.

16 ular matrix of tissue or coatings on cardiac implants.

17 no residual MR in all patients who received implants.

18 ot with gross residual disease or peritoneal implants.

19 ons were found in 28.4%, 21.1%, and 50.5% of implants.

20 leading to faster new bone formation around implants.

21 as successful in 97.1% (n = 34) of attempted implants.

22 xperiments to assess degradation of Mg-based implants.

23 omly assigned to have a first-generation DES implanted.

24 EI-VFQ-25 scores after 3 years of follow-up (implant: 11.9 points; 95% confidence interval [CI], 8.6-

25 ding triamcinolone (4) and the dexamethasone implant (2).

26 All infections occurred in subcutaneous implants (3-incision, n=3; 2-incision, n=4).

27 At implant, 99.5% of patients had a successful conversion o

28 serted in each hemimandible, positioning the implant-abutment interface in either a supracrestal (+1.

29 ults of the Retina Implant Alpha AMS (Retina Implant AG, Reutlingen, Germany) for partial restoration

30 t the initial efficacy results of the Retina Implant Alpha AMS (Retina Implant AG, Reutlingen, German

31 stry, cutting and drilling tools, biomedical implants, among many others.

32 Outcome measures were implant and FPD failures, biologic and prosthetic compli

33 , 164 patients underwent a laparoscopic Linx implant and had a median follow-up of 48 months [interqu

34 e logistic regression model was estimated at implant and patient level to obtain adjusted odds ratios

35 d sRANKL) and bacterial species between peri-implant and periodontal sites in the same individuals, s

36 omes, the cumulative 7-year incidence in the implant and systemic therapy groups, respectively, was l

37 mina (BL) attachment at the interface of the implant and the adjacent epithelium allows for bacterial

38 nuous MarketScan enrollment before and after implant and without a previous diagnosis of HF were dich

39 All participants were implanted and randomized to a paired VNS (n = 16) or con

40 Fifteen subjects with 2 posterior implants and corresponding contralateral teeth were exam

41 uveitic eyes (70% of 90 patients assigned to implant) and 167 uveitic eyes (71% of 90 patients assign

42 ilure, multivessel disease, number of stents implanted, and use of a BMS rather than a DCS.

43 and the tapered junctions of orthopaedic hip implants are known to differ and the debris generated va

44 demonstrated good performance for both RVAD implant (area under the curve, 0.78) and the combined en

45 Analyses using a mouse model of orthopedic implant-associated biofilm formation found that both Sae

46 t P. aeruginosa infection in murine model of implant-associated infection.

47 e and ion release and whether these released implant-associated materials have a local and/or systemi

48 the 54 patients (n = 31) without cataract or implant at diagnosis.

49 peri-implantitis, periodontitis, and healthy implants based on studies that evaluated microbial biofi

50 o identify all patients who underwent a Linx implant between 2007 and 2015 in our Institution.

51 ata were collected on deceased donor kidneys implanted between November 1, 2012, and April 30, 2015,

52 biodegradable bimatoprost sustained-release implant (Bimatoprost SR).

53 BU2 to remove Staphylococcus aureus surgical implant biofilms.

54 nate and adaptive immune system responses to implanted biomaterials in rodents and non-human primates

55 Peri-implant bone level averaged 0.9 +/- 1.1 mm, without sign

56 Implant bone levels were evaluated at initial placement,

57 e significantly associated with greater peri-implant bone loss.

58 e optimized the mechanical properties of the implant by tuning the elastomer branching structure, cro

59 of 44 patients had keratoprosthesis type II implanted by 2 surgeons (C.H.D. and J.C.).

60 right ventricular single-chamber pacemakers implanted by using a femoral percutaneous approach.

61 mber of neurologic treatments rely on neural implants capable of delivering electrical and chemical s

62 tioning the SM to make it more hospitable to implanted cells and showed that HeLa cells could survive

63 ging of gene expression can be used to track implanted cells in vivo but often requires the addition

64 Corticosterone-implanted chicks and their siblings were faster in respo

65 aring aid fitting, and referral for cochlear implant (CI) assessment for each of these groups.

66 ional predictors concur to modulate cochlear implant (CI) performance remains unclear.

67 etion inhibited the growth of subcutaneously implanted cisplatin-resistant human ovarian cancer cells

68 that association between compliance and peri-implant condition was statistically significant (P = 0.0

69 cantly according to PIMT compliance and peri-implant condition.

70 atients with only implants with healthy peri-implant conditions (controls).

71 om the implant shoulder to the first bone-to-implant contact) of -0.15 mm (group A) and 0.12 mm (grou

72 motor cortex of healthy rats compared to non-implanted controls.

73 s using imaging data from a thresholded post-implant CT, (ii) a module to determine the most probable

74 ic vessels, but extravasated less toward the implanted cytokine.

75 activity was recorded intra-operatively via implanted DBS electrodes, whilst simultaneously recordin

76 Results Immune-mismatched stem cell implants demonstrated stronger ferumoxytol enhancement t

77 there are no preclinical in vivo studies in implant dentistry that have investigated the inflammator

78 ally across dentistry with a clear impact in implant dentistry.

79 ndings present an in vivo functional ovarian implant designed with 3D printing, and indicate that sca

80 d as >/=1 spontaneous shocks delivered by an implanted device.

81 A slow-release dexamethasone implant did not improve the primary anatomic success rat

82 The silicone-based implant e-dura embeds interconnects, electrodes, and che

83 rgical epilepsy patients with intracranially implanted electrodes, we trained multivariate classifier

84 d neuroimaging techniques and the surgically implanted electronic and magnetic components of the CI.

85 these implants must be active in the dental implant environment where the implant is bathed in the g

86 The lack of functional peri-implant epithelial sealing with basal lamina (BL) attach

87 come data were collated prospectively for 40 implanted eyes in 23 children (mean age 10.2 +/- 5.3 yea

88 s, technical and biologic complications, and implant failure rate associated with use of DAs and PAs.

89 No postoperative fractures, implant failures or loosening problems occurred; mean Mu

90 299 eyes from 284 patients treated with DEX implant for DME (naive, n = 209; refractory, n = 90).

91 An ICD was implanted for secondary prevention in 10 patients (9.6%)

92 Implants for the treatment of tissue defects should mimi

93 that the bacteria surrounding exposed dental implants form a diverse microbiome regardless of the per

94 ee who were undergoing removal of orthopedic implants from 19 hospitals (17 teaching and 2 academic)

95 g teeth, percentage of teeth with bone loss, implant function time, implant surface, and presence of

96 oefficient P 12 profile in non-annealed H(+) implanted GaAs obtained from the analysis of the time-do

97 e chest was not fully restored in either the implant group (difference, -3.8; P = .001) or autologous

98 compared to 0.199 (0.012) for the surgically implanted group.

99 ol did not show a significant effect on peri-implant hard and soft tissue status in healthy smokers a

100 The microbiota colonizing dental implants has been said to be similar to the microbiome s

101 Implants, however, accumulated less plaque and underwent

102 The Alpha AMS subretinal implant improved visual performance in 5 of 6 participan

103 teral phacoemulsification had an SE-PMMA IOL implanted in 1 eye.

104 The KPro was implanted in 11 eyes of 11 patients 0.9 to 15.5 years of

105 A pacemaker was implanted in 17.5% of patients.

106 as in 17 (2%), and permanent pacemakers were implanted in 181 (21%).

107 )-K(+)-2Cl(-) cotransporter 1 imbalance when implanted in a wild-type dam and prenatally exposed.

108 9L gliosarcoma cells were implanted in both hemispheres in male rats.

109 human breast cancer cell line (MDA-231) was implanted in five mice per group.

110 Tumors implanted in LKB1(endo-/-) mice but not macrophage-speci

111 A multi-electrode array was implanted in M1 contralateral or ipsilateral to the ampu

112 he human brain using intracranial electrodes implanted in patients undergoing treatment for drug-resi

113 ineralization in 3D scaffolds subcutaneously implanted in small animals.

114 determine group assignment and which IOL was implanted in the first eye to undergo surgery.

115 ECT-LV (Safety and Performance of Electrodes implanted in the Left Ventricle) study is a prospective

116 Patients with sequential second Ahmed valves implanted in the same eye from 1994 to 2016 were include

117 but only conformal coated (CC) islets can be implanted in these sites in curative doses.

118 ncreased angiogenesis as compared with those implanted in wild-type mice.

119 Overall, 206 implants in 115 patients fulfilled inclusion criteria.

120 Of these, seven trials with 363 dental implants in 262 participants were included in the analys

121 cochlear electric stimulation using cochlear implants in adult hearing controls and deaf cats.

122 e efficacy and safety of dexamethasone (DEX) implants in paediatric patients with noninfectious inter

123 entify microbiota surrounding exposed dental implants in patients with and without a history of perio

124 ediately loaded (IL) and delayed loaded (DL) implants in smokers and non-smokers.

125 ificantly reduced artifacts due to simulated implants in the femoral head, sternum, and spine (P = 0.

126 Three rats with four implants in the infection group and two rats with three

127 the infection group and two rats with three implants in the sham-infection group were analyzed.

128 osteomyelitis, and biofilm formation on the implants in the surgical legs compared with sham-operate

129 In the surgical implant infection animal model, WLBU2 decreased biofilm

130 Implant infection is a relevant complication but remains

131 s the role of titanium corrosion in the peri-implant inflammatory process, warrant further investigat

132 Forty single-tooth dental implants inserted after placement of bioglass and/or all

133 Sixty-five patients were implanted (intent-to-treat/safety population).

134 immune-matched or mismatched stem cells were implanted into osteochondral defects of the knee joints

135 lar stents manufactured from the JDBM-2 were implanted into rabbits for long-term evaluation.

136 culates with or without rMSC aggregates were implanted into rat critical-sized calvarial defects (CSD

137 reported ultraflexible open mesh electronics implanted into rodent brains by syringe injection that e

138 on of haemoglobin content (54.2%) in sponges implanted into Slco2a1 (-/-), compared to wildtype mice.

139 ne via the hypotonic swelling technique were implanted into the anterior-lateral left ventricular wal

140 onalities have been carefully and rationally implanted into the coordination nanospace of MOF materia

141 Microdialysis probes were implanted into the inguinal adipose tissue depot of C57B

142 Human U87 glioblastoma cells were implanted into the striatum of immunodeficient RNU rats.

143 The model employs a radiopaque marker implanted into the surface of the mouse jejunum, serving

144 Chronic EMG electrodes were implanted into vastus lateralis, biceps femoris posterio

145 le in sinuses with a concave floor and small implant-intruding angles.

146 nce of SSI and NIWCs was slightly higher for implant IR compared with delayed or secondary implant re

147 SI after implant IR, women with an SSI after implant IR were significantly more likely to have anothe

148 Compared with women without an SSI after implant IR, women with an SSI after implant IR were sign

149 in the dental implant environment where the implant is bathed in the glycoprotein-rich salivary flui

150 ters were defined to express both implant-to-implant (ITI) and bone-to-bone (BTB) impingement - cover

151 and 60 days after intravitreal dexamethasone implant (IVDEX).

152 dulloblastoma, spontaneous or orthotopically implanted lesions can be imaged, and tumor morphology an

153 ures were less complicated with fewer stents implanted, less multivessel stenting, less thrombus, and

154 ssion compared with macrophages from placebo-implanted littermates.

155 Peri-implant maintenance compliance >/=2 PIMT/year seems to b

156 However, favorable changes in peri-implant marginal bone level associated with use of DAs s

157 ilm might be transferred into sterile tissue/implant materials during injections for joint spine and

158 rgans could be used to power next-generation implant materials such as pacemakers, implantable sensor

159 ly introduced surfaces (e.g., restorative or implant materials) for prevention of bacterial adhesion

160 tress and interstitial flow on biodegradable implant materials.

161 However, implanted materials can cause further healing impairment

162 ith increasing surgeon preference for porous implants, most studies identified in this literature sea

163 ory responses leading to gingivitis and peri-implant mucositis.

164 Specifically, these implants must be active in the dental implant environmen

165 In a mouse model of orthotopically implanted neuroblastoma cells, inhibition of JAK2/STAT3

166 clude onabotulinumtoxinA and percutaneous or implanted neuromodulators.

167 ly reduce scarring in vivo, compared to hard implants of identical diameter.

168 -contrast tabletop objects not seen with the implant OFF was partially restored with the implant ON i

169 detections (which were at chance level with implant OFF) were recorded in the other 5 participants,

170 tients had runs of NSVT, including 17 before implant on ambulatory monitoring, 44 after ICD implantat

171 Implant ON correct grating detections (which were at cha

172 implant OFF was partially restored with the implant ON in all but 1 participant (P4).

173 perception and temporal resolution with the implant ON were achieved in all participants.

174 A small magnet was surgically implanted on the eye, and changes in the magnet angle as

175 nd are transported to the uterus, where they implant onto the uterine wall.

176 However, use of CRT-D differed by race and implanting operator characteristics.

177 this, young female SD rats were either sham implanted or implanted s.c. with slow-release E2 pellets

178 c profile of peri-implantitis versus healthy implants or periodontitis using conventional microbiolog

179 n be adopted in the designs of dosage forms, implants or stents to enhance the release rate of elutin

180 ower risk of RTT when compared with cemented implants (OR, 0.69; 95% CI, 0.54-0.88; P = .002) but for

181 ne initiation (in-office injection, surgical implant, or pharmacy dispensing) for all testosterone pr

182 t the osteoid matrix that is responsible for implant osseointegration originates from Wnt-responsive

183 with in vivo models of osteotomy healing and implant osseointegration to determine if one type of bon

184 the role that biology and mechanics play in implant osseointegration.

185 s that adjunctive slow-release dexamethasone implant (Ozurdex; Allergan Inc, Irvine, CA) can improve

186 Patients with implants partially comply with scheduled SPT, regardless

187 ts (74.1%) did not have knowledge about peri-implant pathology.

188 hat has been reported for the average dental implant patient population.

189 ignificant differences between MACH and GBAE implants placed in a supracrestal (beta = -0.08; P = 0.4

190 cant differences were encountered except for implants placed in an equicrestal position (P = 0.04).

191 red with sham-operated surgical legs without implant placement and with contralateral nonoperated nor

192 Immediate implant placement at dehiscence buccal bone sites using

193 use of definitive abutments (DAs) at time of implant placement has been introduced to overcome limita

194 s exist regarding influence of apico-coronal implant placement on crestal bone levels.

195 When crestal bone changes from implant placement to 6 months were compared between MACH

196 omen, 274 [57%]; median time from orthopedic implant placement, 11 months [interquartile range, 7-16]

197 presentation is approximately 10 years after implant placement, with 55 of 83 (66%) patients initiall

198 ing the long-cone technique before and after implant placement.

199 to be a viable alternative to PAs at time of implant placement.

200 or pain prevention or control after surgical implant placement.

201 nd 3 to 6, 7 to 11, and 12 to 18 months post-implant placement.

202 al included 117 patients with planned dental implant placement.

203 t time of prosthetic delivery, mesial aspect implant position was equicrestal in 35.4%, subcrestal in

204 y visits found inflammation around teeth and implants positively correlated with IL-1 alpha and IL-1

205 tudies on 9 different PDX groups obtained by implanting primary-cancer fragments harvested from patie

206 mplications, which are mostly related to the implant procedure: cardiac perforation, device dislocati

207 roviding a set of open-source tools for post-implant processing of SEEG data.

208 the use of SEEG Assistant decreases the post implant processing time by more than 2 orders of magnitu

209 decreases, if not eliminates, errors in post implant processing.

210 aim of this study is to develop a novel peri-implant rat model using an established model of polymicr

211 rades or destructs, holds promise in medical implants, reconfigurable electronic devices and/or tempo

212 eir baseline reports, patients who underwent implant reconstruction had decreased fatigue (difference

213 nsideration of delayed rather than immediate implant reconstruction to decrease breast complications

214 Among patients undergoing implant reconstruction, the incidence of SSI was 8.9% (6

215 mplant IR compared with delayed or secondary implant reconstruction.

216 d sexual well-being than those who underwent implant reconstruction.

217 of a 2-part review, we describe indications, implant-related complications, basic function/programmin

218 n of disease status and various patient- and implant-related factors (sex, patient age, smoking, numb

219 ed in a marked propensity for a hematogenous implant-related infection comprised of septic arthritis,

220 ically targeted against Saureus hematogenous implant-related infections.

221 ical site infection within 30 days following implant removal.

222 10-mug, 15-mug, and 20-mug dose strengths of implant, respectively, vs 8.4 mm Hg in topical bimatopro

223 female SD rats were either sham implanted or implanted s.c. with slow-release E2 pellets (20 ng/day f

224 comes of NDIs (3.0 mm) and standard-diameter implants (SDIs) (4.0 to 4.5 mm) supporting fixed partial

225 applied in primates with acutely (few hours) implanted sensors.

226 the long-term performance of the chronically implanted sensors.

227 observed with a mean DIB (distance from the implant shoulder to the first bone-to-implant contact) o

228 formation of the buccal bone wall up to the implant shoulder.

229 according to the sinus floor profile at the implant site.

230 the microbiome of subject-matched tooth and implant sites during native inflammation and in response

231 However, the reduction of implant sites with PD >4 mm and BOP was significantly hi

232 e a local and/or systemic impact on the peri-implant soft and hard tissues.

233 The aim of this study is to compare peri-implant soft tissue parameters (plaque index [PI], bleed

234 2 of 379 [5.8%] vs 129 of 5286 [2.4%]) after implant SR was higher in women who had received adjuvant

235 and standardization in the classification of implant stability related to the values obtained by RFA

236 ginal bone resorption, and no improvement in implant stability.

237 Strut coverage at 3 months of single implanted stents (n=71, primary end point) was 95.2+/-5.

238 These results indicate that an implanted strain sensor is an effective tool to help ass

239 We implanted subcutaneous electrocardiographic monitors (St

240 Similarly, when LLC cells were implanted subcutaneously for the study of spontaneous tu

241 rom an insulin-producing beta-cell line were implanted subcutaneously in autoimmune diabetes-prone NO

242 steroid triamcinolone acetonide (Tr-A) were implanted subcutaneously in rats by using a validated ca

243 degraded and possess low immunogenicity when implanted subcutaneously in rats.

244 ighly metastatic to lymph nodes (B16F10) was implanted subcutaneously on the dorsal hind paw of C57 m

245 re sealed with microinjection ports and then implanted subcutaneously.

246 Peri-implant submucosal microbial samples were collected from

247 itanium particles have been detected in peri-implant supporting tissues.

248 ce between the titanium dioxide layer of the implant surface and the peri-implant tissues.

249 teeth with bone loss, implant function time, implant surface, and presence of plaque) with microbiolo

250 e biofilm formation on zirconia and titanium implant surfaces using an in vitro three-species biofilm

251 k factors for infection following orthopedic implant surgery.

252 ival rate was 96.1% (95.8-96.4), and 20-year implant survival rate was 89.7% (87.5-91.5).

253 For total knee replacement, 10-year implant survival rate was 96.1% (95.8-96.4), and 20-year

254 nificantly higher in PICF samples of healthy implants than in GCF samples of healthy teeth (P = 0.003

255 The reduction in size and ability to implant the new transmitter via injection has reduced th

256 have an uncertain understanding about dental implant therapy and its complications.

257 fore needed for applications such as medical implants, tissue engineering, soft robotics, and wearabl

258 de layer of the implant surface and the peri-implant tissues.

259 attenuation map in the presence of metallic implants, to be used for whole-body attenuation correcti

260 hree parameters were defined to express both implant-to-implant (ITI) and bone-to-bone (BTB) impingem

261 After 12 months, implants treated without AM showed significant reduction

262 = .002) but for other types of readmission, implant type had no significant association with readmis

263 levels were evaluated at initial placement, implant uncovery, prosthetic delivery, and 3 to 6, 7 to

264 undergoing surgery for removal of orthopedic implants used for treatment of fractures below the knee,

265 een reported following removal of orthopedic implants used for treatment of fractures below the knee.

266 Nine cochlear implant users rated the extent to which the song was out

267 For cochlear implant users, combined electro-acoustic stimulation (EA

268 lve size, which was then (1) compared to the implanted valve size and (2) to a theoretical transcathe

269 Comparison of teeth and implants via general linear models based on orthogonal p

270 between intravitreous fluocinolone acetonide implant vs systemic therapy and long-term visual and oth

271 n of maxillary first molars, a titanium mini-implant was inserted.

272 The XEN 45 mu-fistula implant was successfully placed in both eyes and adequat

273 us infection in which an orthopedic titanium implant was surgically placed in the legs of mice follow

274 structure as a commercially available dental implant was used.

275 Mean prosthesis size implanted was slightly smaller in patients requiring AVR

276 06 patients treated with at least one dental implant were reviewed.

277 height at the mesial and distal side of each implant were taken, and the sinus floor configuration wa

278 All implants were clinically stable during a mean follow-up

279 Coated implants were found to significantly reduce scarring in

280 Four types of replicate implants were used in this study: 1) acellular dTBs; 2)

281 Livers of 19 Wistar rats were implanted with 5 x 10(6) rat colorectal liver metastasis

282 Fifty-eight male patients-18 implanted with a continuous-flow LVAD, 16 patients with

283 c shock despite optimal medical therapy were implanted with an extracorporeal life support.

284 pecific malfunctions was discovered in those implanted with an HM II versus an HVAD (0.55 versus 0.39

285 iagnosed with nontractable epilepsy who were implanted with entorhinal cortical electrodes performing

286 derived macrophages from ovariectomized mice implanted with estrogen exhibited enhanced IL-4-induced

287 ves survival of rats and mice orthotopically implanted with gliosarcoma tumors or glioma stem-like ce

288 ents (four males and three females) who were implanted with intracranial depth electrodes.

289 he DOCA-salt rats were randomly selected and implanted with osmotic minipumps delivering vehicle or s

290 gue Dawley rats (350-450 g) were chronically implanted with pulsed Doppler flow probes (renal and mes

291 METHODS AND Pigs implanted with single-chamber implantable cardioverter d

292 METHODS AND Patients implanted with subcutaneous implantable cardioverter-def

293 rs and distant untreated tumors in some mice implanted with the MB49 bladder cancer cells.

294 ollow-ups were completed by 193 and 127 eyes implanted with the myopic pIOL and by 40 and 20 eyes imp

295 d with the myopic pIOL and by 40 and 20 eyes implanted with the toric pIOL, respectively.

296 arch 2007 to January 2015, 105 patients were implanted with venoarterial-extracorporeal membrane oxyg

297 Among this selected cohort of 105 patients implanted with venoarterial-extracorporeal membrane oxyg

298 In the second one, three animals were implanted with zeranol and three were fed a diet contain

299 Collected data were based on 156 implants with an average of 6.5 +/- 3.4 years (range: 1

300 6 months, grit-blasted acid-etched (GBAE) PS implants with and without a MACH neck were randomly inse

301 titis (cases) and from 69 patients with only implants with healthy peri-implant conditions (controls)